Literature DB >> 6990765

Cerebral blindness and oculomotor nerve palsies in toxoplasmosis.

W B Wilson, J A Sharpe, J H Deck.   

Abstract

We studied the clinicopathologic and neuro-ophthalmic manifestations of central nervous system toxoplasmosis in two patients who were being treated with immunosuppressive chemotherapy, one for renal transplantation and the other for systemic lupus erythematosis. Both pateints had oculomotor nerve palsies and later developed visual loss from cerebral involvement. Multifocal central nervous system toxoplasmosis appeared as a complication of their systemic diseases.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6990765     DOI: 10.1016/0002-9394(80)90293-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Presentation and management of parasellar and suprasellar metastatic mass lesions.

Authors:  J C Kattah; R M Silgals; H Manz; J G Toro; A Dritschilo; F P Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-01       Impact factor: 10.154

2.  Acute acquired toxoplasmosis causing neuroptico-meningoencephalitis in an immunocompetent boy.

Authors:  C Confavreux; P Girard-Madoux; T Moulin; D Boisson; A Vighetto; G Aimard; M Devic
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-07       Impact factor: 10.154

3.  Toxoplasmosis in patients with an autoimmune disease and immunosuppressive agents: A multicenter study and literature review.

Authors:  Marie-Fleur Durieux; Jean-Guillaume Lopez; Maher Banjari; Karine Passebosc-Faure; Marie-Pierre Brenier-Pinchart; Luc Paris; Gilles Gargala; Sabine Berthier; Julie Bonhomme; Cathy Chemla; Isabelle Villena; Pierre Flori; Emilie Fréalle; Coralie L'Ollivier; Florian Lussac-Sorton; José Gilberto Montoya; Estelle Cateau; Christelle Pomares; Loïc Simon; Dorothée Quinio; Florence Robert-Gangneux; Hélène Yera; Marc Labriffe; Anne-Laure Fauchais; Marie-Laure Dardé
Journal:  PLoS Negl Trop Dis       Date:  2022-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.